Abstract 1681: Strong synergistic activity of an EZH1/2 dual inhibitor, HM97662, in combination with standard chemotherapy in preclinical models of advanced solid tumors
Year: 2025
Type: conference-abstract
Source: Cancer Research
Institution: Hanmi Pharmaceutical (South Korea)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4409625897
